Cited by 1,014Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchPrion Diseases and Protein Misfolding

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Open access

Burdick, D, Soreghan, B, Kwon, M, Kosmoski, J, Knauer, M, Henschen, A, Yates, J, Cotman, C, Glabe, C·1992·Journal of Biological Chemistry

DOI 10.1016/s0021-9258(18)48529-8

Open this paper in CoChat — free account

Abstract

The amyloid A4 or beta peptide is a major component of extracellular amyloid deposits that are a characteristic feature of Alzheimer's disease. We synthesized a series of peptide analogs of the A4/beta peptide which are progressively longer at their carboxyl termini, including 42- and 39-residue peptides which represent the major forms of the A4/beta peptide in senile plaque and the hereditary cerebral hemorrhage with amyloidosis form, respectively. All peptides tested, beta 1-28 through beta 1-42, formed amyloid-like fibrils and previously unreported thin sheet-like structures which stained with thioflavin T and Congo Red. The solubility of beta 1-42 and shorter peptides was pH and concentration dependent, with a broad insolubility profile in the pH range of 3.5-6.5 and at concentrations above 0.75 mg/ml. Only peptides of 42 residues or longer were significantly insoluble at pH 7.4. beta 1-47 and beta 1-52 peptides are highly insoluble in aqueous media but are soluble at 40 mg/ml in the alpha helix-promoting solvent, 1,1,1,3,3,3-hexafluoro-2-propanol. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that the beta 1-42 peptide migrates as a series of higher molecular mass aggregates whereas shorter peptides migrate as monomers. Aggregation is also dependent on pH, peptide concentration, and time of incubation in aqueous medium. These results indicate that the length of the hydrophobic carboxyl terminus of the A4/beta peptide is important in determining the s…

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(18)48529-8

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233
Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity
Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., & Ito, H. (1988) · Nature · doi:10.1038/331530a0 · Cited by 1,083
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction
Sarin, V. K., Kent, S. B. H., Tam, J. P., & Merrifield, R. B. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90704-1 · Cited by 1,066
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors
Ponte, P. A., Gonzalez‐DeWhitt, P. A., Schilling, J., Miller, J., Hsu, D. K., Greenberg, B., Davis, K. L., Wallace, W., Lieberburg, I. M., Fuller, F. H., et al. (1988) · Nature · doi:10.1038/331525a0 · Cited by 1,050

Show all 42 references

Research works printed but not linked: 4

Beyreuther, 1986, Discoveries Neurosci., 3, 68
Glabe, 1990, Technique, 2, 138
Joachim, 1989, Am. J. Pathol., 135, 309
Masters, 1987, Ciba Found. Symp., 126, 49

Sorted by citations

Items 201–300 of 1,000

Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer’s disease pathology
Power, J. H. T., Asad, S., Chataway, T., Chegini, F., Manavis, J., Temlett, J. A., Jensen, P. H., Blumbergs, P. C., & Gai, W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0373-3 · Cited by 153
Taurine and central nervous system disorders
Menzie, J., Pan, C., Prentice, H. M., & Wu, J. (2012) · Amino Acids · doi:10.1007/s00726-012-1382-z · Cited by 153
C-Terminal PEG Blocks the Irreversible Step in β-Amyloid(10-35) Fibrillogenesis
Burkoth, T. S., Benzinger, T. L. S., Jones, D. N. M., Hallenga, K., Meredith, S. C., & Lynn, D. G. (1998) · Journal of the American Chemical Society · doi:10.1021/ja980566b · Cited by 152
Fusogenic Properties of the C-terminal Domain of the Alzheimer β-Amyloid Peptide
Pillot, T., Goethals, M., Vanloo, B., Talussot, C., Brasseur, R., Vandekerckhove, J. S., Rosseneu, M., & Lins, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28757 · Cited by 152
Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red.
Hirakura, Y., Lin, M., & Kagan, B. L. (1999) · PubMed · Cited by 151
Somatic Mosaicism in the Human Genome
Freed, D. N., Stevens, E. L., & Pevsner, J. (2014) · Genes · doi:10.3390/genes5041064 · Cited by 156
Reversible Random Coil-.beta.-Sheet Transition of the Alzheimer .beta.-Amyloid Fragment (25-35)
Terzi, E., Hoelzemann, G., & Seelig, J. (1994) · Biochemistry · doi:10.1021/bi00172a009 · Cited by 151
Solution Structure of Residues 1-28 of the Amyloid .beta.-Peptide
Talafous, J., Marcinowski, K. J., Klopman, G., & Zagorski, M. G. (1994) · Biochemistry · doi:10.1021/bi00191a006 · Cited by 149
Aβ aggregation and possible implications in Alzheimer's disease pathogenesis
Bharadwaj, P. R., Dubey, A. K., Masters, C. L., Martins, R. N., & Macreadie, I. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00609.x · Cited by 155
In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information
Lansbury, P. T. (1992) · Biochemistry · doi:10.1021/bi00145a001 · Cited by 145
Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ1–42 mutants of familial Alzheimer's disease at positions 21–23
Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T., & Shirasawa, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00430-8 · Cited by 146
Potential Link between Amyloid β-Protein 42 and C-terminal Fragment γ 49–99 of β-Amyloid Precursor Protein
Sato, T., Dohmae, N., Qi, Y. A., Kakuda, N., Misonou, H., Mitsumori, R., Maruyama, H., Koo, E. H., Haass, C., Takio, K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211161200 · Cited by 150
Untitled work
(1999) · doi:10.1002/(sici)1097-4547(19990815)57:4
Diffuse Plaques Contain C-terminal Aβ42and not Aβ40: Evidence From Cats and Dogs
Cummings, B. J., Satou, T., Head, E., Milgram, N. W., Cole, G. M., Savage, M. J., Podlisny, M. B., Selkoe, D. J., Siman, R. G., Greenberg, B., et al. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00062-0 · Cited by 140
Self-citation
Direct Observations of Amyloid β Self-Assembly in Live Cells Provide Insights into Differences in the Kinetics of Aβ(1–40) and Aβ(1–42) Aggregation
Esbjörner, E. K., Chan, F., Rees, E. J., Erdélyi, M., Luheshi, L. M., Bertoncini, C. W., Kaminski, C. F., Dobson, C. M., & Schierle, G. S. K. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.03.014 · Cited by 138
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Lee, M., Yu, W., Shih, Y., Chen, C., Guo, Z., Huang, S., Chan, J. C. C., & Chen, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-23122-x · Cited by 141
Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins and the Immunohistochemistry of Sporadic Alzheimer’s Disease and Cerebral Amyloid Angiopathy Cases
Barelli, H., Lebeau, A., Vizzavona, J., Delaère, P., Chevallier, N., Drouot, C., Marambaud, P., Ancolio, K., Buxbaum, J. D., Khorkova, O., et al. (1997) · Molecular Medicine · doi:10.1007/bf03401708 · Cited by 143
Temperature-dependent β-sheet formation in β-amyloid Aβ1–40 peptide in water: uncoupling β-structure folding from aggregation
Gursky, O., & Aleshkov, S. B. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00228-9 · Cited by 140
Iron: A Pathological Mediator of Alzheimer Disease?
Bishop, G. M., Robinson, S. R., Liu, Q., Perry, G. L., Atwood, C., & Smith, M. A. (2002) · Developmental Neuroscience · doi:10.1159/000065696 · Cited by 139
Amyloid precursor protein and its homologues: a family of proteolysis-dependent receptors
Jacobsen, K. T., & Iverfeldt, K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0020-8 · Cited by 139
The Interaction between Apolipoprotein E and Alzheimer's Amyloid β-Peptide Is Dependent on β-Peptide Conformation
Golabek, A. A., Soto, C. A., Vogel, T., & Wısnıewskı, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10602 · Cited by 137
Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation.
Eriksson, S., Janciauskiene, S. M., & Lannfelt, L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2313 · Cited by 137
Calcium and Neuronal Injury in Alzheimer's Disease: Contributions of β‐Amyloid Precursor Protein Mismetabolism, Free Radicals, and Metabolic Compromisea
MATTSON, M. P. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44401.x · Cited by 166
Senile plaque composition and posttranslational modification of amyloid-β peptide and associated proteins
Atwood, C., Martins, R. N., Smith, M. A., & Perry, G. L. (2002) · Peptides · doi:10.1016/s0196-9781(02)00070-0 · Cited by 142
Amyloid-β Annular Protofibrils Evade Fibrillar Fate in Alzheimer Disease Brain
Lasagna‐Reeves, C. A., Glabe, C. G., & Kayed, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.236257 · Cited by 139
Self-citation
Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.
Pedersen, W. A., Kloczewiak, M. A., & Blusztajn, J. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8068 · Cited by 134
Acidic pH promotes the formation of toxic fibrils from β-amyloid peptide
Su, Y., & Chang, P.-T. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03322-9 · Cited by 135
Deposition of Monomeric, Not Oligomeric, Aβ Mediates Growth of Alzheimer's Disease Amyloid Plaques in Human Brain Preparations
Tseng, B. P., Esler, W. P., Clish, C. B., Stimson, E. R., Ghilardi, J. R., Vinters, H. V., Mantyh, P. W., Lee, J. P., & Maggio, J. E. (1999) · Biochemistry · doi:10.1021/bi990718v · Cited by 132
Protection by EGb 761 against β-amyloid-induced neurotoxicity: Involvement of NF-κB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation
Longpré, F., Garneau, P., Christen, Y., & Ramassamy, C. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.015 · Cited by 132
Fibrillar β-Amyloid-stimulated Intracellular Signaling Cascades Require Vav for Induction of Respiratory Burst and Phagocytosis in Monocytes and Microglia
Wilkinson, B. L., Koenigsknecht-Talboo, J., Grommes, C., Lee, C. Y. D., & Landreth, G. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600627200 · Cited by 131
Improved electrophoretic separation and immunoblotting of beta‐amyloid (Aβ) peptides 1–40, 1–42, and 1–43
Wiltfang, J., Av, S., Schnierstein, B., Kelemen, G., Matthies, U., Klafki, H., Staufenbiel, M., Huether, G., Rüther, E., & Kornhuber, J. (1997) · Electrophoresis · doi:10.1002/elps.1150180332 · Cited by 130
Decreased pH in the aging brain and Alzheimer's disease
Decker, Y., Németh, E., Schomburg, R., Chemla, A., Fülöp, L., Menger, M. D., Liu, Y., & Fassbender, K. C. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.12.007 · Cited by 129
Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D
Ladror, U. S., Snyder, S. W., Wang, G. T., Holzman, T. F., & Krafft, G. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32325-6 · Cited by 128
Intracellular Aβ1-42 Aggregates Stimulate the Accumulation of Stable, Insoluble Amyloidogenic Fragments of the Amyloid Precursor Protein in Transfected Cells
Yang, A. J., Knauer, M. F., Burdick, D., & Glabe, C. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14786 · Cited by 126
Self-citation
Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons
Watt, J. A., Pike, C. J., Walencewicz, A. J., & Cotman, C. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)91191-6 · Cited by 128
Self-citation
Aβ25–35 induces rapid lysis of red blood cells: contrast with Aβ1–42 and examination of underlying mechanisms
Mattson, M. P., Begley, J. G., Mark, R. J., & Furukawa, K. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00824-x · Cited by 124
Charge Alterations of E22 Enhance the Pathogenic Properties of the Amyloid β‐Protein
Melchor, J. P., McVoy, L., & Nostrand, W. E. V. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742209.x · Cited by 125
Lack of alzheimer pathology after β-amyloid protein injections in rat brain
Games, D., Khan, K., Soriano, F., Keim, P. S., Davis, D. L., Bryant, K., & Lieberburg, I. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90057-5 · Cited by 127
A chemical approach to elucidate tin mechanism of transthyretin and β-protein amyloid fibril formation
Kelly, J. W., & Lansbury, P. T. (1994) · Amyloid · doi:10.3109/13506129409148451 · Cited by 125
Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in alzheimer's disease
Cummings, B. J., Su, J. H., Geddes, J. W., Van Nostrand, W. E., Wagner, S. L., Cunningham, D. D., & Cotman, C. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90265-4 · Cited by 120
Self-citation
Sequence Determinants of Enhanced Amyloidogenicity of Alzheimer Aβ42 Peptide Relative to Aβ40
Kim, W., & Hecht, M. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505763200 · Cited by 123
Distribution and Fluidizing Action of Soluble and Aggregated Amyloid β-Peptide in Rat Synaptic Plasma Membranes
Mason, R. P., Jacob, R. F., Walter, M. F., Mason, P. E., Avdulov, N. A., Chochina, S. V., Igbavboa, U., & Wood, W. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18801 · Cited by 123
Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons
Good, T. A., Smith, D. O., & Murphy, R. M. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79570-x · Cited by 122
Current therapeutic targets for the treatment of Alzheimer’s disease
Grill, J. D., & Cummings, J. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.29 · Cited by 123
Human apolipoprotein A–I binds amyloid-β and prevents Aβ-induced neurotoxicity
Paula-Lima, A. C., Tricerri, M. A., Brito-Moreira, J., Bomfim, T. R., Oliveira, F. F., Magdesian, M. H., Grinberg, L. T., Panizzutti, R., & Ferreira, S. T. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.12.003 · Cited by 121
α-Mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation
Wang, Y., Xia, Z., Xu, J., Wang, Y., Hou, L., Qiu, Y. L., & Chen, H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.016 · Cited by 119
Molecular Chaperone Dysfunction in Neurodegenerative Diseases and Effects of Curcumin
Maiti, P., Manna, J., Veleri, S., & Frautschy, S. A. (2014) · BioMed Research International · doi:10.1155/2014/495091 · Cited by 121
Internalization of β-Amyloid Peptide by Primary Neurons in the Absence of Apolipoprotein E
Saavedra, L., Mohamed, A., Ma, V., Kar, S., & de Chaves, E. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701823200 · Cited by 118
Mechanisms of Neurotoxicity Associated with Amyloid β Deposition and the Role of Free Radicals in the Pathogenesis of Alzheimer's Disease: A Critical Appraisal
Sayre, L. M., Zagorski, M. G., Surewicz, W. K., Krafft, G. A., & Perry, G. L. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970009n · Cited by 119
Contributions of DNA Damage to Alzheimer’s Disease
Lin, X., Kapoor, A., Gu, Y., Chow, M. J., Peng, J., Zhao, K., & Tang, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051666 · Cited by 117
Amyloid-Beta (Aβ) D7H Mutation Increases Oligomeric Aβ42 and Alters Properties of Aβ-Zinc/Copper Assemblies
Chen, W.-T., Hong, C., Lin, Y.-T., Chang, W.-H., Huang, H.-T., Liao, J., Chang, Y.-J., Hsieh, Y.-F., Cheng, C.-Y., Liu, H.-C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035807 · Cited by 119
The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis
Soto, C. A., & Castaño, E. M. (1996) · Biochemical Journal · doi:10.1042/bj3140701 · Cited by 116
β‐Cyclodextrin interacts with the Alzheimer amyloid β‐A4 peptide
Camilleri, P., Haskins, N. J., & Hewlett, D. R. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80467-2 · Cited by 117
Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases
Migliorini, C., Porciatti, E., Łuczkowski, M., & Valensin, D. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.07.004 · Cited by 117
Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein.
Bahr, B. A., Hoffman, K. B., Yang, A. J., Hess, U. S., Glabe, C. G., & LYNCH, G. S. (1998) · PubMed · Cited by 116
Self-citation
Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease
Wilkinson, B. L., Cramer, P. E., Varvel, N. H., Reed-Geaghan, E. G., Jiang, Q., Szabo, A., Herrup, K., Lamb, B. T., & Landreth, G. E. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.06.014 · Cited by 118
Amyloid-β oligomers in cellular models of Alzheimer’s disease
Fontana, I. C., Zimmer, A. R., Rocha, A. S., Gosmann, G., Souza, D. O., Lourenco, M. V., Ferreira, S. T., & Zimmer, E. R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15030 · Cited by 115
Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ1–42, in differentiated PC12 cells
Burdick, D., Kosmoski, J., Knauer, M. F., & Glabe, C. G. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01262-0 · Cited by 102
Self-citation
In vitro studies of amyloid β-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692→Gly) Alzheimer's disease
Walsh, D. M., Hartley, D. M., Condron, M. M., Selkoe, D. J., & Teplow, D. B. (2001) · Biochemical Journal · doi:10.1042/bj3550869 · Cited by 114
Examining the zinc binding site of the amyloid‐β peptide
Yang, D., McLaurin, J., Qin, K., Westaway, D. A., & Fraser, P. E. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01767.x · Cited by 113
Plasmin Cleavage of the Amyloid β-Protein: Alteration of Secondary Structure and Stimulation of Tissue Plasminogen Activator Activity
Nostrand, W. E. V., & Porter, M. D. (1999) · Biochemistry · doi:10.1021/bi990610f · Cited by 113
MAPK recruitment by β‐amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time
Bell, K. A., O’Riordan, K. J., Sweatt, J. D., & Dineley, K. T. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02722.x · Cited by 117
Influence of Hydrophobic Teflon Particles on the Structure of Amyloid β-Peptide
Giacomelli, C. E., & Norde, W. (2003) · Biomacromolecules · doi:10.1021/bm034151g · Cited by 113
Architecture of the Alzheimer?s A�P Ion Channel Pore
Arispe, N. J. (2004) · The Journal of Membrane Biology · doi:10.1007/s00232-003-0638-7 · Cited by 117
β-Amyloid neurotoxicity: A discussion of in vitro findings
Cotman, C. W., Pike, C. J., & Copani, A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90060-b · Cited by 112
Self-citation
A helix-to-coil transition at the ε-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis
Sato, T., Tang, T.-C., Reubins, G., Fei, J. Z., Fujimoto, T., Kienlen‐Campard, P., Constantinescu, S. N., Octave, J., Aimoto, S., & Smith, S. O. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812261106 · Cited by 111
Alzheimer's disease and soluble Aβ
Wısnıewskı, T., Ghiso, J. A., & Frangione, B. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90105-8 · Cited by 112
Complement Component C1q Modulates the Phagocytosis of Aβ by Microglia
Webster, S. D., Yang, A. J., Margol, L., Garzon-Rodriguez, W., Glabe, C. G., & Tenner, A. J. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7260 · Cited by 138
Self-citation
Probing the Kinetics of β-Amyloid Self-Association
Murphy, R. M., & Pallitto, M. M. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4253 · Cited by 109
The neuropeptide PACAP attenuates β-amyloid (1–42)-induced toxicity in PC12 cells
Onoue, S., Endo, K., Ohshima, K., Yajima, T., & Kashimoto, K. (2002) · Peptides · doi:10.1016/s0196-9781(02)00085-2 · Cited by 109
Intracellular Accumulation of Insoluble, Newly Synthesized Aβn-42 in Amyloid Precursor Protein-transfected Cells That Have Been Treated with Aβ1–42
Yang, A. J., Chandswangbhuvana, D., Shu, T., Henschen, A., & Glabe, C. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.29.20650 · Cited by 108
Self-citation
Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic Implications by Natural Products
Rather, M. A., Khan, A., Alshahrani, S., Rashid, H., Qadri, M. M., Rashid, S., Alsaffar, R. M., Kamal, M. A., & Rehman, M. U. (2021) · Mediators of Inflammation · doi:10.1155/2021/9982954 · Cited by 114
β‐Amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH
Klug, G. M., Lošić, D., Supundi, Subasinghe, S., Aguilar, M., Martin, L. L., & Small, D. H. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03815.x · Cited by 109
Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's Disease neuropathology
Xiang, Z. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00282-2 · Cited by 107
Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide
Jao, S., Ma, K., Talafous, J., Orlando, R., & Zagorski, M. G. (1997) · Amyloid · doi:10.3109/13506129709003835 · Cited by 107
Modulation of beta-amyloid precursor protein trafficking and processing by the low density lipoprotein receptor family
Cam (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-8 · Cited by 106
Transglutaminase facilitates the formation of polymers of the β-amyloid peptide
Dudek, S. M., & Johnson, G. V. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90688-2 · Cited by 106
Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA
Wang, J., Xu, G. M., Slunt, H. H., Gonzales, V., Coonfield, M. L., Fromholt, D., Copeland, N. G., Jenkins, N. A., & Borchelt, D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.005 · Cited by 110
Antibody-Mediated Phagocytosis of the Amyloid β-Peptide in Microglia Is Differentially Modulated by C1q
Webster, S. D., Galvan, M. D., Ferran, E., Garzon-Rodriguez, W., Glabe, C. G., & Tenner, A. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7496 · Cited by 104
Self-citation
Review: Model Peptides and the Physicochemical Approach to β-Amyloids
Lynn, D. G., & Meredith, S. C. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4287 · Cited by 105
Hemodynamic changes during aging associated with cerebral blood flow and impaired cognitive function
Ajmani, R. S., Metter, E. J., Rajadas, J., Ingram, D. K., Spangler, E. L., Abugo, O. O., & Rifkind, J. M. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00118-4 · Cited by 104
The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils.
Nordstedt, C., Näslund, J., Tjernberg, L. O., Karlström, A. R., Thyberg, J., & Terenius, L. Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47347-4 · Cited by 103
Conformational Changes of the Amyloid β‐Peptide (1–40) Adsorbed on Solid Surfaces
Giacomelli, C. E., & Norde, W. (2005) · Macromolecular Bioscience · doi:10.1002/mabi.200400189 · Cited by 103
NMR Studies of the Zn 2+ Interactions with Rat and Human β-Amyloid (1−28) Peptides in Water-Micelle Environment
Gaggelli, E., Janicka-Kłos, A., Jankowska, E., Kozłowski, H., Migliorini, C., Molteni, E., Valensin, D., Valensin, G., & Wieczerzak, E. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp075168m · Cited by 102
Alternate Aggregation Pathways of the Alzheimer β-Amyloid Peptide: Aβ Association Kinetics at Endosomal pH
Gorman, P. M., Yip, C. M., Fraser, P. E., & Chakrabartty, A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01279-2 · Cited by 100
Alzheimer's amyloid β interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids
Koudinov, A. R., Berezov, T. T., Kumar, A. R., & Koudinova, N. V. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00207-6 · Cited by 102
Specific Compositions of Amyloid-β Peptides as the Determinant of Toxic β-Aggregation
Yoshiike, Y., Chui, D., Akagi, T., Tanaka, N., & Takashima, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212785200 · Cited by 105
Small heat shock proteins inhibit in vitro Aβ1–42 amyloidogenesis
Kudva, Y. C., Hiddinga, H. J., Butler, P. C., Mueske, C. S., & Eberhardt, N. L. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01180-0 · Cited by 103
In Vitro Growth of Alzheimer's Disease β-Amyloid Plaques Displays First-Order Kinetics †
Esler, W. P., Stimson, E. R., Ghilardi, J. R., Vinters, H. V., Lee, J. P., Mantyh, P. W., & Maggio, J. E. (1996) · Biochemistry · doi:10.1021/bi951685w · Cited by 102
Structures of the Amyloid β-Peptides Aβ1–40 and Aβ1–42 as Influenced by pH and a d -Peptide
Olubiyi, O. O., & Strodel, B. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp2076337 · Cited by 100
Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity
Kim, H., Park, C. H., Ho, S., Lee, J., Lee, S., Kim, Y., Rah, J., Jeong, S., & Suh, Y. (2000) · The FASEB Journal · doi:10.1096/fj.99-0809com · Cited by 97
The amyloid‐β peptide and its role in Alzheimer's disease
Clippingdale, A. B., Wade, J. D., & Barrow, C. J. (2001) · Journal of Peptide Science · doi:10.1002/psc.324 · Cited by 103
Anti-Viral Properties of Amyloid-β Peptides
Bourgade, K., Dupuis, G., Frost, E. H., & Fülöp, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160517 · Cited by 97
Nerve Growth Factor, Neural Stem Cells and Alzheimer’s Disease
Heese, K., Low, J. W., & Inoue, N. (2006) · Neurosignals · doi:10.1159/000094383 · Cited by 97
Soluble multimeric Alzheimer β(1–40) pre-amyloid complexes in dilute solution
LeVine, H. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00052-g · Cited by 95
Endogenous β-amyloid production in presenilin-deficient embryonic mouse fibroblasts
Armogida, M., Petit-Paitel, A., Vincent, B., Scarzello, S., da Costa, C. A., & Checler, F. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1030 · Cited by 96
Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review
Yuksel, M., & Tacal, Ö. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172415 · Cited by 99
Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro
Liao, M.-C., & Van Nostrand, W. E. (2010) · Biochemistry · doi:10.1021/bi901994d · Cited by 92
Structure of β-amyloid fibrils and its relevance to their neurotoxicity: Implications for the pathogenesis of Alzheimer’s disease
Irie, K., Murakami, K., Masuda, Y., Morimoto, A., Ohigashi, H., Ohashi, R., Takegoshi, K., Nagao, M., Shimizu, T., & Shirasawa, T. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.99.437 · Cited by 104
Vision function abnormalities in Alzheimer disease
Tzekov, R., & Mullan, M. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2013.10.002 · Cited by 94

Authors: Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C.
Affiliations: University of California, Irvine (US)
ORCID: Henschen, A
Yates, J
Cotman, C
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1992-01
Volume: 267
Issue: 1
Pages: 546-554
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1016/s0021-9258(18)48529-8
OpenAlex: W2130144581
Cited by: 1,014
References: 42
Citations by year: 2026: 7 · 2025: 8 · 2024: 14 · 2023: 21 · 2022: 14 · 2021: 29 · 2020: 20 · 2019: 22 · 2018: 28 · 2017: 27 · 2016: 30 · 2015: 29 · 2014: 37 · 2013: 29 · 2012: 31
FWCI: 28.77
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 10516 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: National Institutes of Health (1r35ag007918-01, 5r01hd021379-14)
National Institute on Aging (AG07918)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD21379)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords: amyloid-beta, Alzheimer's disease, peptide analogues, amyloid fibril formation, peptide aggregation, solubility, pH dependence, Congo red staining, thioflavin T staining, amyloid plaques, hexafluoroisopropanol, amyloid deposition
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Amyloid, Chromatography, High Pressure Liquid, Electrophoresis, Polyacrylamide Gel, Hydrogen-Ion Concentration, Kinetics, Microscopy, Electron, Molecular Sequence Data, Peptides, Mass Spectrometry, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks